DrugPatentWatch Database Preview

Amphastar Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for AMPHASTAR PHARM, and what generic and branded alternatives to AMPHASTAR PHARM drugs are available?

AMPHASTAR PHARM has eleven approved drugs.

Summary for Amphastar Pharm

US Patents:	0
Tradenames:	10
Ingredients:	9
NDAs:	11
Patent Litigation for Amphastar Pharm:	See patent lawsuits for Amphastar Pharm

Drugs and US Patents for Amphastar Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amphastar Pharm	KETOROLAC TROMETHAMINE	ketorolac tromethamine	INJECTABLE;INJECTION	076209-002	Jul 21, 2004	AP	RX	No	No
Amphastar Pharms Inc	MEDROXYPROGESTERONE ACETATE	medroxyprogesterone acetate	INJECTABLE;INJECTION	077235-001	Nov 28, 2017	AB	RX	No	No
Amphastar Pharms Inc	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	209832-001	Dec 18, 2017	AP	RX	No	No
Amphastar Pharms Inc	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	209933-001	Sep 25, 2017	AP	RX	No	No
Amphastar Pharm	ENOXAPARIN SODIUM (PRESERVATIVE FREE)	enoxaparin sodium	INJECTABLE;SUBCUTANEOUS	076684-006	Sep 19, 2011	AP	RX	No	No
Amphastar Pharms Inc	MEDROXYPROGESTERONE ACETATE	medroxyprogesterone acetate	INJECTABLE;INJECTION	077334-001	Nov 28, 2017	AB	RX	No	No
Amphastar Pharms Inc	ISOPROTERENOL HYDROCHLORIDE	isoproterenol hydrochloride	INJECTABLE;INJECTION	210106-001	Jun 18, 2018	AP	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Amphastar Pharm
• Amphastar Pharms Inc